Keyword Analysis & Research: caredx
Keyword Research: People who searched caredx also searched
Search Results related to caredx on Search Engine
-
CareDx | The Transplant Company™
https://caredx.com/
WebWe are committed to improving transplant patient outcomes through innovative, noninvasive testing solutions and services throughout the entire patient journey. Being the industry leader isn’t enough. We relentlessly pursue science and technology in order to improve long-term organ survival.
DA: 90 PA: 98 MOZ Rank: 54
-
Company | CareDx
https://caredx.com/company/
WebWe are committed to improving transplant patient outcomes by providing innovative and intelligent solutions throughout the entire patient journey. Our mission-driven culture is fueled by the embodiment of five core values permeating across the company—innovation, patient centricity, accountability, continuous improvement, and a culture built ...
DA: 7 PA: 8 MOZ Rank: 34
-
Products & Services | CareDx
https://caredx.com/products-and-services/
WebCareDx is the leading provider of noninvasive surveillance tests to help identify injury and rule out rejection. Learn More. Transplant Lab Products. Rapid processing and exceptional precision pushes human leukocyte antigen typing into next-gen status. Learn More. Digital Transplant Solutions.
DA: 52 PA: 48 MOZ Rank: 82
-
Login | CareDx
https://caredx.com/login/
WebCareDx Portals. Welcome to our login page, your gateway to the portal tailored to your needs whether you are a healthcare provider, distributor, or researcher. Testing Services (United States) Digital Health Solutions. Lab Products (International) Distributors. Research. Online Testing Services Ordering. CarePortal.
DA: 58 PA: 13 MOZ Rank: 59
-
Patients & Caregivers | CareDx
https://caredx.com/patients-and-caregivers/
WebCareDx provides a unique combination of noninvasive tests and patient support services to help you through your heart transplant journey. Learn More. An at-home blood draw service that helps make it easier for you to stay on track …
DA: 43 PA: 12 MOZ Rank: 41
-
Transplant Services | CareDx
https://caredx.com/products-and-services/transplant-services/
WebTransplant Surveillance. Bringing personalized care to transplantation. CareDx is dedicated to making transplant care better in every way. We want to give patients the tools to extend graft life as long as possible. And with this philosophy, CareDx has become the leading partner in transplant centers across the U.S. Follow the links below to ...
DA: 57 PA: 24 MOZ Rank: 65
-
Pipeline | CareDx
https://caredx.com/company/pipeline/
WebCareDx is furthering the science of transplant. management with new products and clinical studies. Pipeline. Studies. Solid Organ Pipeline. Kidney Transplant. AiKidney. Suite of AI-derived algorithms and predictive tools to assist clinicians with making more informed decisions. AlloMap Kidney.
DA: 73 PA: 82 MOZ Rank: 37
-
CareDx, Inc. | LinkedIn
https://www.linkedin.com/company/care-dx-inc
WebCareDx, Inc. | 16,990 followers on LinkedIn. Dedicated to transplant patients. Leading with innovation. | CareDx: Transforming Transplant Patient Care Through Novel Surveillance Management ...
DA: 19 PA: 25 MOZ Rank: 68
-
CareDx Enrolls First Patients in the Largest Digital Study in
https://investors.caredx.com/news/news-details/2021/CareDx-Enrolls-First-Patients-in-the-Largest-Digital-Study-in-Transplant-Using-AlloCare-to-Assess-Patient-Outcomes-11-18-2021/default.aspx
WebNov 18, 2021 · CareDx Enrolls First Patients in the Largest Digital Study in Transplant Using AlloCare to Assess Patient Outcomes. November, 18, 2021. TEAMMATE Study to Assess Impact in 4,000 Patients Across 100 Transplant Centers. SOUTH SAN FRANCISCO, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant …
DA: 32 PA: 29 MOZ Rank: 4
-
CareDx Reports Third Quarter 2023 Results - CareDx
https://investors.caredx.com/news/news-details/2023/CareDx-Reports-Third-Quarter-2023-Results/default.aspx
WebCareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today reported financial results for the third quarter ended September 30, 2023.
DA: 35 PA: 64 MOZ Rank: 28